Long-term trends in mortality and AIDS-defining events among perinatally HIV-infected children across Europe and Thailand by Judd, A et al.
TUAB0103
Long-term trends in mortality and AIDS-defining events
among perinatally HIV-infected children across Europe and
Thailand
A Judd1; E Chappell1; K Doerholt2; L Galli3; C Giaquinto4; D Gibb1;
T Goetghebuer5; S Le Coeur6; A Noguera Julian7; A Turkova1;
R Goodall1 and European Pregnancy and Paediatric Hiv Cohort
Collaboration (EPPICC)
1MRC Clinical Trials Unit, University College London (UCL), London,
United Kingdom. 2St George’s Hospital NHS Trust, London, United
Kingdom. 3University of Florence, Florence, Italy. 4PENTA Foundation,
Padova, Italy. 5Hopital St Pierre, Brussels, Belgium. 6IRD 174 - PHPT,
Chiang Mai, Thailand. 7Hospital Sant Joan de Deu Barcelona,
Barcelona, Spain
Presenting author email: a.judd@ucl.ac.uk
Introduction: There are limited data on the prognostic effects of time-
updated covariates on long-term mortality rates of perinatally HIV-
infected children after starting ART.We analyzed individual patient data
from 19 cohorts in 16 European countries and Thailand in EPPICC.
Methods: Perinatally HIV-infected children aged B18 starting cART
were followed until death, loss to follow-up (LTFU), transfer to adult
care, their 21st birthday or last visit to 31/12/2013. Crude rates of
death and first AIDS-defining events were calculated. Baseline and
time-updated risk factors for death 5/6 months of cART and pro-
gression to AIDS were assessed using inverse-probability-censoring-
weighted Cox models to account for informative censoring of LTFU.
Results: Of 3527 children, 32, 20, 18 and 30% were from the UK/
Ireland, Thailand, Russia/Ukraine and the rest of Europe, respectively.
At cART initiation, median (IQR) age was 5.2 (1.49.3) years, and
42% had severe WHO immunological stage. Median follow-up was
5.6 (2.98.7) years. There were 94 deaths and 174 first AIDS-defining
events, of which 43 (46%) and 79 (45%) occurred within 6 months of
cART initiation. The crude mortality rate was 2.50 (95% confidence
interval (CI): 1.863.38)/100 person-years (PY) in the 56 month
period, and 0.27 (0.210.36) thereafter. In total, 59 (63%) {31 56
months} deaths were from HIV-related infections, 19 (20%) {9} were
HIV-related non-infectious conditions, 12 (13%) {1} were HIV-
unrelated and 4 (4%) {2} were unknown. The rate of first AIDS-
defining event was 0.88 (0.761.02)/100PY, including 31 (18%) HIV
encephalopathy, 29 (17%) tuberculosis and 25 (14%) HIV wasting
syndrome. The Table shows multivariable predictors of increased
risk of death 6 months of cART. Predictors for death 56 months
(baseline only) and progression to AIDS (baseline and time-updated)
were broadly similar.
21st International AIDS Conference Abstract Supplement
Journal of the International AIDS Society 2016, 19 (Suppl 5)
http://www.jiasociety.org/index.php/jias/article/view/21264 | http://dx.doi.org/10.7448/IAS.19.6.21264 Oral Abstracts
4
Conclusions: Almost half of deaths occurred 56 months of cART,
after which current severe WHO immune stage, low BMI-for-age z-
score and fewer VL copy-years suppressed were the strongest
predictors for mortality. The raised mortality risk in those aged
]14 and in middle-income countries raises concern.
Abstract TUAB0103Table 1. Predictors of death 6 months of cART
Variable Adjusted HR (95% CI) P
Country type Middle-income (Russia, Ukraine, Thailand) ref 0.028
High-income 0.5 (0.20.9)
Calendar year at cART start 1997B2004 ref 0.035
2004B2008 0.4 (0.20.8)
]2008 0.5 (0.11.5)
BMI-for-age z-score at cART start 0 0.2 (0.10.6) 0.045
3 to 0 ref
B3 0.5 (0.21.6)
VL copy-years suppressed (5400 c/ml) since cART Initiation
(per year increase)
0.7 (0.60.9) 0.001
Current (time updated) age (years) B2 4.2 (1.412.7) 0.002
2B5 0.2 (0.11.8)
5Bl4 ref
]14 2.1 (1.04.2)
Current (time updated) WHO immune stage severe No 0.1 (0.10.2) B0.001
Yes ref
Current (time updated) BMl-for-age z-score 0 1.1 (0.42.8) B0.001
3 to 0 ref
B3 19.5 (7.252.8)
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